Announced
Completed
Synopsis
Unchained Labs, a life sciences company, completed the acquisition of NanoView Biosciences, a company which is developing proprietary products that support research, translation and delivery of precision medicine. Financial terms were not disclosed. “NanoView has been dedicated to helping exosome researchers characterize these complex particles. We’re just getting started with viral vector characterization and there’s no better company than Unchained Labs to help us get LentiView into the hands of gene therapy researchers,” Jerry Williamson, NanoView Biosciences CEO.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.